T-group (topology)
266.1.1 Thymidylate synthase/dCMP hydroxymethylase
Ligands and drugs
1,314
Member domains
833
with ligand contacts (≤ 4 Å)
63.4% of members
824
with DrugDomain annotations
62.7% of members
809
with a DrugBank compound
61.6% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 266.1.1 belongs to X-group 266 Thymidylate synthase/dCMP hydroxymethylase, which binds 9.5 ligand superclasses per 20 proteins, broader than 88% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03800 | UMP | Deoxyuridine monophosphate | 423 |
| DB03761 | UFP | 5-fluoro-2'-deoxyuridine-5'-monophosphate | 118 |
| DB03541 | CB3 | 10-Propargyl-5,8-Dideazafolic Acid | 98 |
| DB00293 | D16 | Raltitrexed | 52 |
| DB03345 | BME | Mercaptoethanol | 17 |
| DB03798 | DCM | 2'-Deoxycytidine-5'-Monophosphate | 16 |
| DB11596 | FFO | Levoleucovorin | 16 |
| DB00563 | MTX | Methotrexate | 15 |
| DB00642 | LYA | Pemetrexed | 10 |
| DB11256 | C2F | Levomefolic acid | 9 |
| DB01643 | TMP | Thymidine monophosphate | 8 |
| DB04447 | DTT | 1,4-Dithiothreitol | 8 |
| DB02031 | THG | (6S)-5,6,7,8-tetrahydrofolic acid | 6 |
| DB02338 | NDP | NADPH | 5 |
| DB00143 | GSH | Glutathione | 4 |
| DB03818 | TP2 | N-[Tosyl-D-Prolinyl]Amino-Ethanethiol | 4 |
| DB04438 | BVP | Brivudine monophosphate | 4 |
| DB04696 | GA9 | 4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN | 4 |
| DB02015 | DHF | Dihydrofolic Acid | 3 |
| DB02256 | DUR | 2'-Deoxyuridine | 3 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| UMP | 2'-DEOXYURIDINE 5'-MONOPHOSPHATE | 426 |
| UFP | 5-FLUORO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE | 118 |
| CB3 | 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID | 98 |
| D16 | TOMUDEX | 52 |
| CL | CHLORIDE ION | 19 |
| BME | BETA-MERCAPTOETHANOL | 17 |
| DCM | 2'-DEOXYCYTIDINE-5'-MONOPHOSPHATE | 17 |
| F89 | S)-2-(5(((1,2-DIHYDRO-3-METHYL-1-OXOBENZO(F)QUINAZOLIN-9-YL)METHYL)AMINO)1-OXO-2-ISOINDOLINYL)GLUTARIC ACID | 17 |
| UMC | 2'-deoxy-5'-uridylic acid | 16 |
| MTX | METHOTREXATE | 15 |
| 2XB | N-{4-[(2-amino-4-hydroxy-7H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl]benzoyl}-L-glutamic acid | 14 |
| LYA | 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID | 12 |
| FFO | N-[4-({[(6S)-2-amino-5-formyl-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid | 10 |
| C2F | 5-METHYL-5,6,7,8-TETRAHYDROFOLIC ACID | 9 |
| D96 | N-{4-[(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl]benzene-1-carbonyl}-D-glutamic acid | 9 |
| NDU | 2'-DEOXY-5-NITROURIDINE 5'-MONOPHOSPHATE | 9 |
| OE7 | 2-({4-[(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl]benzene-1-carbonyl}amino)-4-chlorobenzoic acid | 9 |
| OED | [2-({4-[(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl]benzene-1-carbonyl}amino)-4-methoxyphenyl]acetic acid | 9 |
| OF7 | [2-({4-[(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl]benzene-1-carbonyl}amino)phenyl]acetic acid | 9 |
| 1JY | N-(4-{[(6S)-2-(hydroxymethyl)-4-oxo-4,6,7,8-tetrahydro-1H-cyclopenta[g]quinazolin-6-yl](prop-2-yn-1-yl)amino}benzoyl)-L-gamma-glutamyl-D-glutamic acid | 8 |